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Nucleolin is a multifunctional protein that carries several post-translational modiﬁcations. We char-
acterized nucleolin acetylation and developed antibodies speciﬁc to nucleolin K88 acetylation. Using
this antibody we show that nucleolin is acetylated in vivo and is not localized in the nucleoli, but
instead is distributed throughout the nucleoplasm. Immunoﬂuorescence studies indicate that acet-
ylated nucleolin is co-localized with the splicing factor SC35 and partially with Y12. Acetylated
nucleolin is expressed in all tested proliferating cell types. Our ﬁndings show that acetylation
deﬁnes a new pool of nucleolin which support a role for nucleolin in the regulation of mRNA mat-
uration and transcription by RNA polymerase II.
Structured summary of protein interactions:
SC35 physically interacts with Nucleolin by anti bait coimmunoprecipitation (View interaction)
Nucleolin and SC35 colocalize by ﬂuorescence microscopy (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Nucleolin was ﬁrst identiﬁed as one of the major nucleolar
phosphoproteins [1]. Because of its predominant nucleolar locali-
zation, the different functions of nucleolin in ribosome biogenesis
have been extensively studied [2]. In particular, nucleolin is in-
volved in the ﬁrst processing step of pre-rRNA maturation
in vitro [3] and it interacts with numerous ribosomal proteins
[4]. Nucleolin–rRNA interaction studies suggest that nucleolin
could be involved in the co-transcriptional folding of pre-rRNA
which is necessary for the correct maturation of pre-rRNA [5]. In-
deed, in nucleolin knockout DT40 cells [6], the processing of 45S
pre-rRNA is moderately affected. However, the most prominent ef-
fect of nucleolin knockout or silencing, is on pre-rRNA accumula-
tion suggesting that nucleolin could be involved in some aspects
of pre-rRNA transcription elongation [6–10]. Nucleolin has also
been involved in DNA repair, mRNAs metabolism, internalization
of growth factors and viral ligands and virus replication [5].These multiple functions can be achieved via numerous pro-
tein–protein interactions, and probably also thanks to the numer-
ous post-translational modiﬁcations (PTM) whose functions are
still largely unexplored.
The best characterized PTM of nucleolin is undoubtedly the
phosphorylation of the N-terminal domain [11,12], which has been
involved in the regulation of transcription [13,14] and nucleic acid
interaction [15]. The C-terminal domain of nucleolin is the site of
NG,NG-dimethylarginine [16] that can modulate the interaction of
nucleolin with nucleic acids [17]. Nucleolin is also glycosylated
in human U397 cells [18].
Acetylation is another PTM that has been extensively studied.
p300/CBP, the GNAT family of histone acetytransferase (HAT) acet-
ylates a large number of non-histone proteins [19]. Acetylome
analysis by mass spectrometry identiﬁed acetylated residues on
nucleolin [20].
In this study, we identiﬁed several acetylated lysine in the
N-terminal domain of nucleolin and we developed an antibody
speciﬁc to nucleolin acetylated lysine 88 (NCL-K88ac). Using this
antibody, we demonstrated that a fraction of nucleolin could be
acetylated in vivo. Interestingly, we found that NCL-K88ac is not
localized within the nucleolus, but rather in nucleoplasmic
speckles that colocalized with splicing factors SC35. This speckle
418 S. Das et al. / FEBS Letters 587 (2013) 417–424localization was found in HeLa cells and in stimulated Peripheral
Blood Mononuclear Cells (PBMC).
2. Materials and methods
2.1. In vitro acetylation assay
In vitro acetylation assays were performed using 2 lg of pro-
teins, incubated at 30 C for 30 min in a 30 ll acetylation buffer
(50 mM Tris–HCl (pH 8.0), 10% (vol/vol) glycerol, 1 mM dithio-
threitol, 1 mM phenylmethylsulfonyl ﬂuoride, 0.1 mM EDTA (pH
8.0), 10 mM sodium butyrate) and 0.5 ll of 3.3 Ci/mmol [3H]acet-
yl-CoA and analyzed as described in the legend of Supplementary
Fig. 1. For the mass acetylation reaction, 2 lg of baculovirus-ex-
pressed nucleolin and 100 ng full-length p300 were incubated in
the presence of 50 lM acetyl-CoA at 37 C for 1.5 h. To achieve efﬁ-
cient acetylation, p300 and acetyl-CoA were added at every 30-min
interval.
2.2. Generation of polyclonal antibodies speciﬁc for acetylated
nucleolin and characterization of the in vivo status of nucleolin
acetylation
Based on the identiﬁed acetylation sites by mass spectrometry,
four different peptides having acetylated lysine residues (AcK)
were designed (see sequences in Supplementary Fig. 2). Each acet-
ylated peptide was used for immunization of a rabbit (Covalab,
Lyon). The speciﬁcity of the four resulting serums was ﬁrst checked
by an ELISA with the acetylated and non-acetylated peptides. The
serum obtained from the immunization with AcNcl1 peptide
showed the highest speciﬁcity, and was chosen to perform the
experiments described in this manuscript. For some experiments
(as indicated in the text) we used the puriﬁed IgG of AcNcl1 that
were puriﬁed using Protein A Agarose beads (Thermo Scientiﬁc).
Immunoprecipitation experiments using nucleolin antibodies were
done as described previously [10].
2.3. Cell culture, siRNA transfection and immunoﬂuorescence studies
HeLa cells were cultured in Dulbecco’s modiﬁed Eagle medium
(DMEM, Gibco) supplemented with 10% foetal bovine serum (FBS)
(Gibco) at 37 C in 5% CO2 incubator. HeLa cells (6  105) were
transfected twice with siRNA Ncl2 and Ncl4 (Eurogentec) using
Lipofectamine 2000 (Invitrogen) as described previously [8]. As a
siRNA control we used Stealth high GC siRNA (Invitrogen). Proteins
were harvested at 96 h after the ﬁrst transfection, and analysed by
Western blot.
2.4. Antibodies
The following antibodies were used: A rabbit polyclonal anti-
body against human nucleolin no 5567 developed by our laboratory
and used previously [21], a rabbit polyclonal antibody against hu-
man acetylated nucleolin (AcNcl1) (Covalab, Lyon; this study),
anti-acetyl-Histone H3 (Lys14) (17-305,Upstate) anti-SC35
(ab11826, Abcam), anti-Y12 (ab3138, Abcam), anti-Coilin (IH10)
(ab87913, Abcam), anti-acetyl lysine (ab21623, Abcam), andmouse
monoclonal anti-nucleolin antibody (KAM-CP100, Stressgen).3. Results
3.1. Nucleolin is acetylated both in vivo and in vitro
With the aim to determine if nucleolin could be acetylated
in vivo, we prepared a nuclear S2 extract which is the ﬁrst stepof nucleolin puriﬁcation from HeLa cells [21]. (Fig. 1A, B). Western
blot on this extract with global anti-acetyl Lysine antibody
(Ab21623, Abcam) clearly detects a faint band corresponding to
nucleolin size (Fig. 1C) suggesting that a fraction of nucleolin pro-
tein could be acetylated in vivo. To conﬁrm this data, and identify
the lysine acetyltransferase(s) (KAT) that are able to post-transla-
tionaly modify nucleolin, we carried out an in vitro acetylation as-
say using different KATs and [3H]acetyl-CoA. The normalized KATs
(Supplementary Fig. 1) were tested for their ability to acetylate
nucleolin in vitro (Fig. 1D). Interestingly, it was found that only
p300 and PCAF were able to acetylate nucleolin in vitro (Fig. 1D,
lanes 4 and 6).
3.2. Identiﬁcation of nucleolin acetylation sites
We set out to identify the acetylation sites by mass-spectrome-
try. Direct analysis of the puriﬁed nucleolin or immunoprecipita-
tions with global anti-acetyl lysine antibodies were not
successful, probably because only a small fraction of nucleolin is
acetylated (see later) and because of the inefﬁciency of IP with
the used global-acetyl lysine antibodies. Therefore, we tried the
identiﬁcation of nucleolin acetylation sites after an in vitro acety-
lation reaction using cold Acetyl CoA (see Supplementary experi-
mental procedures). Three independent experiments were
performed and several acetylated lysine sites were identiﬁed
(Fig. 2B). Interestingly, all acetylation sites were found in the ﬁrst
150 amino-acids of the N-terminal domain of nucleolin.
To further characterize nucleolin acetylation, we raised acetyla-
tion-speciﬁc antibodies against acetylated peptides. Four peptides
covering 8 of these acetylation sites were designed (Supplemen-
tary Fig. 2A) and used for rabbit immunization. The anti-AcNcl1
antibody (raised against the AcNcl1 peptide) was further studied
in this manuscript. The speciﬁcity of AcNcl1 serum was then char-
acterized by ELISA with the AcNcl1 modiﬁed and unmodiﬁed pep-
tide used for immunization (Supplementary Fig. 2B). These data
clearly indicate that the AcNcl1 serum is speciﬁcally directed
against the acetyl modiﬁcation of the peptide. In addition, cross
reactivity of AcNcl1 serum with AcNcl2, AcNcl3 and AcNcl4 modi-
ﬁed peptides was also studied (Supplementary Fig. 2C) and the
reactivity toward acetylated histones was determined by Western
blot (Supplementary Fig. 2D). These experiments show that AcNcl1
serum present a good speciﬁcity only for the AcNcl1 peptide. Since
AcNcl1 peptide contains 2 acetylated Lysines (K79 and K88), ELISA
tests were performed with two new peptides carrying only one of
the acetylated Lysine (Supplementary Fig. 3). Remarkably, only the
peptide AcNcl1_Pep1 carrying acetylated K88 reacted efﬁciently
(and as AcNcl1 peptide) with the AcNcl1 serum, indicating that this
serum contains antibodies speciﬁc to this nucleolin K88 acetylated
lysine (NCL-K88ac).
Then, the speciﬁcity of this AcNcl1 antibody was characterized
by Western blot analysis using full-length nucleolin puriﬁed from
baculovirus that was subjected or not to an in vitro acetylation
reaction with p300 (Fig. 2C). AcNcl1 antibody reacts only very
weakly with baculovirus puriﬁed nucleolin (lane 1) whereas a
strong signal is detected after the acetylation reaction (lane 2). In
addition, with a HeLa whole cell extract, AcNcl1 serum detects only
one weak protein bands at the size of nucleolin (Fig. 2D). These
experiments suggest that this AcNcl1 serum is speciﬁc of nucleolin
acetylation and that the level of nucleolin acetylation is probably
low in the cell.
To further demonstrate that AcNcl1 antibody is speciﬁc to
nucleolin, we performed a series of immuno-precipitation (IP)
experiments from HeLa cells with AcNcl1 serum and with another
previously well characterized polyclonal nucleolin antibody [21]
(Fig. 2E). After an IP with AcNcl1 serum, nucleolin Ab gives a strong
signal (lane 5, second row), and inversely after IP with nucleolin
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Fig. 1. Acetylation of nuclear S2 extract and nucleolin proteins. (A) Analysis of nuclear S2 proteins (15 lg) separated on a 10% SDS–PAGE and stained with Coomassie blue.
Molecular weight markers (kDa) are indicated on the left of the ﬁgure. (B) Endogenous nucleolin from HeLa nuclear S2 extract revealed by Western blot with anti-nucleolin
antibody 5567. (C) Acetylation of proteins of the HeLa nuclear S2 extract revealed by Western blot with anti-pan acetylated lysine antibody (Abcam 21623). (D) Nucleolin is
acetylated in vitro by p300 and PCAF. In vitro acetylation assay was carried out with nucleolin as substrate in the absence (lane 3) or presence of p300 (lanes 1, 2 and 4). The
acetylation reactions were also performed with different PATs as indicated on the ﬁgure. Lanes 1, 4, 5, 6, 7, 8 and 9 show the acetylation reaction in the presence of [3H]acetyl-
CoA and lanes 2 and 3 in the absence of [3H]acetyl-CoA. Reaction products were resolved on a 10% SDS–PAGE. The gel was stained with Coomassie blue to demonstrate that
equivalent substrate was used in each reaction (lower panels), and subsequently [3H]acetate reaction products were visualized by autoradiography of the same gel (upper
panels). Note the autoacetylation of PCAF (lane 6) indicated by an asterisk.
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protein (lane 4, ﬁrst row). As previously shown, AcNcl1 serum
gives only a weak signal with total ‘‘input’’ proteins, suggesting
again that the level of NCL-K88ac is low in cells. Altogether, these
experiments show that this AcNcl1 serum is speciﬁc to nucleolin
acetylation and that nucleolin is indeed acetylated in vivo.
3.3. NCL-K88ac localizes in the nucleoplasm and is colocalized with
different nuclear markers
We used our AcNcl1 Ab to determine the cellular localization of
NCL-K88ac by immunoﬂuorescence (Fig. 3). Interestingly, AcNcl1
Ab did not label the nucleoli structures as typical nucleolin antibod-
ies do, but instead detected nucleoplasmic speckles (Fig. 3A). The
nucleolin polyclonal antibody which strongly labels the nucleoli
also gives some faint signal in the nucleoplasm that colocalize with
the signal of AcNcl1 Ab (Fig. 3A) which conﬁrm the Western blot
analysis (Fig. 2E) showing that the polyclonal Ab recognize also
the pool of acetylated nucleolin. The signal speciﬁcity was demon-
strated by treating the cells with nucleolin siRNA (Supplementary
Fig. 4). Inhibition of deacetylases with a sodium butyrate (NaBu)
treatment (Fig. 3B–E) leads to a twofold increase of the signal ob-
served by Western blot (Fig. 3B and C) and immunoﬂuorescence
(Fig. 3D and E)with the AcNcl1 Abwhereas the signal obtainedwith
the nucleolin polyclonal Ab is not changed (Fig. 3B). Since global
nucleolin Ab detectsmainly nucleolin in the nucleoli and associated
with the coding region of rDNA chromatin using ChIP-seq [10] we
performed a ChIP-seq analysis of NCL-K88ac interaction with rDNA
(Supplementary Fig. 5). In contrast with the interaction of nucleolinwith rDNA, NCL-K88ac does not seem signiﬁcantly bound to rDNA
chromatin. Altogether, these data conﬁrm that AcNcl1 Ab is speciﬁc
of nucleolin acetylation and show that NCL-K88ac is excluded from
the nucleolus and predominantly localized in the nucleoplasm.
To identify the nucleoplasmic structures labeled with AcNcl1
Ab, we studied the distribution of the AcNcl1 antibody and differ-
ent nuclear markers (Fig. 4) that are also known to give a speckle-
like distribution such as the splicing factor SC35 and the snRNP
marker Y12. The amount of colocalization was quantiﬁed by NIH
ImageJ software and is depicted as Pearson’s coefﬁcient (Fig. 4, bot-
tom right insert of each panel, and 4D) where a number near +1
suggests perfect correlation between 2 biomolecules, and a num-
ber near 0 indicates no correlation. Strikingly, the signal obtained
with AcNcl1 Ab is almost completely co-localized with SC35
(Fig. 4A) and partially with Y-12 (Fig. 4B). In contrast, AcNcl1 Ab
did not co-localize at all with coilin (Fig. 4C). In agreement with
the co-localization of NCL-K88ac and SC35, immunoprecipitation
with an anti-SC35 antibody is able to pull down NCL-K88ac as de-
tected by AcNcl1 Ab (Supplementary Fig. 6), suggesting that NCL-
K88ac and SC35 are indeed present in the same cellular structures.
3.4. Acetylation of nucleolin in different cell lines
The level of NCL-K88ac was checked in different cells (Fig. 5A).
Acetylated nucleolin as detected by AcNcl1 seems absent from rest-
ing PBMC (lane 1) but is present in stimulated cells (lane 2). Interest-
ingly, the level of expression of NCL-K88ac follows the level of
expression of nucleolin in the different cell lines as the ratio of the
signal AcNcl1/Ncl is very similar in all tested cell lines (Fig. 5B). Like
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420 S. Das et al. / FEBS Letters 587 (2013) 417–424in HeLa cells (Fig. 3A), acetylated nucleolin detected by AcNcl1 Ab is
perfectly co-localized with the splicing factor SC35 in stimulated
PBMC (Fig. 5C).4. Discussion
In this report, we show that nucleolin is acetylated in vivo.
We identiﬁed several acetylated lysines, which are present
exclusively within the ﬁrst 150 N-terminal residues of nucleolin.
Other acetylated residues may however exist as the purpose of
this work was not to have an exhaustive analysis of nucleolin
PTM. Also, it is not known if all these modiﬁcations are presentsimultaneously in the same molecules. NCL-K88ac represent a
distinct pool of protein with a distinct cellular localization:
NCL-K88ac is apparently absent from the nucleolar structures,
but is present in speckle structures in the nucleoplasm (Figs. 3
and 4).
The absence of NCL-K88ac from the nucleoli suggests that it is
not involved in ribosome biogenesis and, in particular, in the reg-
ulation of transcription by RNAPI. ChIP-Seq with a polyclonal anti-
body show that nucleolin is associated with the coding region of
rDNA, similar to the distribution of UBF and RNAPI subunit
RPA116 [10,22]. However, ChIP-Seq with AcNcl1 does not detect
any signiﬁcant binding of NCL-K88ac on rDNA chromatin
(Supplementary Fig. 5). This ﬁnding is in agreement with the
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immunoﬂuorescence.
IfNCL-K88ac is not involved inRNAPI regulation, thenwhat could
be its function? Interestingly, itwas found that nucleolin in thepres-
ence of PCAF enhanced IRF-2-dependant H4 promoter activity [23].
Recruitment of nucleolin to acetylated IRF-2 is required for this pro-
moter activity. However, since we show in this manuscript that
nucleolin is also a substrate of PCAF, it would be interesting to
reevaluate the role of nucleolin acetylation in this transcriptional
regulation. NPM1 that share many functional similarities with
nucleolin [24] is also acetylated by p300 [25]. Acetytlated-NPM1 is
predominantly localized in the nucleoplasm [26] and has an en-
hanced ability to activate transcription from chromatin templates.However, we were unable to see any colocalization for NCL-K88ac
with transcriptionally active RNA polymerase II or any activation
of transcription on chromatin template in vitro (data not shown).
It is remarkable that NCL-K88ac distribution in the nucleoplasm
is co-localized with the nuclear domains enriched in splicing factor
SC35 and with the snRNP marker Y12 (Fig. 4). These nuclear speck-
les (also called interchromatin granule clusters, IGC) are very dy-
namic structures [27] and are also enriched in many other mRNA
splicing factors, RNA polymerase II subunits and diverse
transcription factors [28] but, transcription and pre-mRNA splicing
do not seem to take place within these structures [29]. The
association of NCL-K88ac with these speckles suggests two possi-
ble functions for NCL-K88ac. First, it was shown that the
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unit, which is involved in transcription elongation was co-localized
with nuclear speckles [30]. As nucleolin has been involved in the
transcription of several Pol II genes and in transcription elongation
[5] it is also possible that the presence of NCL-K88ac in the speck-
les participates to the formation of transcription elongation com-
plexes for the nearby genes.
The second possibility is that nucleolin participates in the splic-
ing of some mRNAs. There are many examples of interactions of
nucleolin with different mRNAs with different effects on mRNA
stability and translation. Recently, a pull down assay followed by
microarray analysis identiﬁed several hundred of potential nucleo-
lin mRNA targets [31]. Although the nucleolin interactome is notknown, several reports describe the interaction of nucleolin with
proteins involved in pre-mRNA splicing in particular, different
hnRNPs [32]. Our results also show that SC35 complexes contain
NCL-K88ac. Recently, RNP complexes formed on a speciﬁc HIV
pre-mRNA splicing site (SLS2-A7 RNA transcripts) in HeLa cell nu-
clear extracts identiﬁed hnRNP A1, nucleolin, hnRNP H and hnRNP
K that directly interact with SLS2-A7 RNA [33]. Nucleolin binds to a
cluster of successive canonical nucleolin recognition element (NRE
motifs) [21] in SLS2-A7 RNA. The authors showed a strong effect of
hnRNP K on HIV-1 alternative splicing, but they have not tested the
effect of the interaction of nucleolin with HIV-1 mRNA. This opens
the possibility that the interaction of nucleolin with this RNA af-
fects its alternative splicing.
424 S. Das et al. / FEBS Letters 587 (2013) 417–424The characterization and functional signiﬁcance of nucleolin
post-translational modiﬁcations are still unexplored. In this work,
we provide evidence that nucleolin is acetylated in vivo and this
modiﬁcation drastically changes its cellular localization. The pres-
ence of NCL-K88ac in nuclear speckles suggests that this nucleolin
pool may be involved in pre-mRNA synthesis or metabolism. The
speciﬁc antibodies developed against NCL-K88ac herein, should
be useful to explore this novel nucleolin function.
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